Esperion Therapeutics
ESPR
#6816
Rank
โ‚น37.74 B
Marketcap
โ‚น192.38
Share price
8.06%
Change (1 day)
162.37%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -โ‚น3.39 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.27 Billion. In 2023 the company made an earning of -โ‚น12.68 Billion, an increase over its 2022 earnings that were of -โ‚น14.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น3.39 Billion-73.33%
2023 -โ‚น12.68 Billion-15.03%
2022 -โ‚น14.93 Billion-20.61%
2021 -โ‚น18.8 Billion84.28%
2020 -โ‚น10.2 Billion35.75%
2019 -โ‚น7.52 Billion-55.71%
2018 -โ‚น16.97 Billion19.57%
2017 -โ‚น14.19 Billion125.39%
2016 -โ‚น6.3 Billion51.43%
2015 -โ‚น4.16 Billion36.45%
2014 -โ‚น3.05 Billion43.55%
2013 -โ‚น2.13 Billion145.26%
2012 -โ‚น0.87 Billion
2002 -โ‚น2.47 Billion-7.81%
2001 -โ‚น2.68 Billion15.03%
2000 -โ‚น2.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น43.89 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.02 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น102.27 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น419.29 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น8.43 Billion 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น17.06 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA